Product Code: ETC6186157 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s neurostimulation devices market is centered on products that use electrical impulses to stimulate the nervous system, thereby treating conditions such as chronic pain, depression, Parkinsons disease, and epilepsy. These devices, including transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS), are becoming increasingly popular due to their effectiveness in treating refractory conditions. The market is expected to grow with technological advancements and increasing patient demand for non-pharmacological treatment options.
The neurostimulation devices market in Australia is growing as these devices provide effective treatments for a variety of neurological conditions, including chronic pain, depression, and Parkinsons disease. Neurostimulation therapies, such as deep brain stimulation (DBS), spinal cord stimulation, and transcranial magnetic stimulation (TMS), are gaining acceptance due to their ability to provide relief when traditional treatments fail. The market is also influenced by ongoing research and development, which aims to improve the efficacy, safety, and convenience of these devices. With the increasing prevalence of neurological disorders, demand for neurostimulation devices is expected to rise.
The neurostimulation devices market in Australia deals with challenges such as invasive procedure risks, device malfunctions, limited patient awareness, and concerns regarding long-term device safety and efficacy.
Neurostimulation devices are gaining popularity in Australia for their use in treating chronic pain, depression, and epilepsy. The market is highly receptive to innovative, non-invasive solutions such as TMS and vagus nerve stimulation. Investors can tap into this segment by funding device development, supporting clinical trials, or partnering with healthcare providers to integrate these technologies into care protocols.
Neurostimulation devices are regulated as Class IIb or Class III medical devices under the TGA framework. Government initiatives encouraging innovation in implantable technologies, alongside reimbursement options under Medicare and private health insurance, boost market accessibility.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neurostimulation Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neurostimulation Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neurostimulation Devices Market - Industry Life Cycle |
3.4 Australia Neurostimulation Devices Market - Porter's Five Forces |
3.5 Australia Neurostimulation Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Australia Neurostimulation Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Neurostimulation Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neurostimulation Devices Market Trends |
6 Australia Neurostimulation Devices Market, By Types |
6.1 Australia Neurostimulation Devices Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Australia Neurostimulation Devices Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Australia Neurostimulation Devices Market Revenues & Volume, By Internal Neuromodulation, 2021- 2031F |
6.1.4 Australia Neurostimulation Devices Market Revenues & Volume, By External Neuromodulation (Non-Invasive), 2021- 2031F |
6.2 Australia Neurostimulation Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Neurostimulation Devices Market Revenues & Volume, By Parkinson's disease, 2021- 2031F |
6.2.3 Australia Neurostimulation Devices Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.2.4 Australia Neurostimulation Devices Market Revenues & Volume, By Depression, 2021- 2031F |
6.2.5 Australia Neurostimulation Devices Market Revenues & Volume, By Dystonia, 2021- 2031F |
6.2.6 Australia Neurostimulation Devices Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.7 Australia Neurostimulation Devices Market Revenues & Volume, By Other Applications, 2021- 2031F |
7 Australia Neurostimulation Devices Market Import-Export Trade Statistics |
7.1 Australia Neurostimulation Devices Market Export to Major Countries |
7.2 Australia Neurostimulation Devices Market Imports from Major Countries |
8 Australia Neurostimulation Devices Market Key Performance Indicators |
9 Australia Neurostimulation Devices Market - Opportunity Assessment |
9.1 Australia Neurostimulation Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Australia Neurostimulation Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Neurostimulation Devices Market - Competitive Landscape |
10.1 Australia Neurostimulation Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Neurostimulation Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |